Nemtabrutinib With Venetoclax and Obinutuzumab in Patients With Chronic Lymphocytic Leukemia
1d agoen
From the article
Conditions : Chronic Lymphocytic Leukemia Interventions : Drug: Nemtabrutinib; Drug: Venetoclax; Drug: Obinutuzumab Sponsors : Medical College of Wisconsin Not yet recruiting
Continue reading on clinicaltrials.gov
Comments
Sign in to join the conversation.
No comments yet. Be the first.